These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15974948)

  • 1. Engineering chemokines to develop optimized HIV inhibitors.
    Hartley O; Offord RE
    Curr Protein Pept Sci; 2005 Jun; 6(3):207-19. PubMed ID: 15974948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and chemokines: implications for therapy and vaccine.
    Lusso P
    Vaccine; 2002 May; 20(15):1964-7. PubMed ID: 11983255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
    Hartley O; Dorgham K; Perez-Bercoff D; Cerini F; Heimann A; Gaertner H; Offord RE; Pancino G; Debré P; Gorochov G
    J Virol; 2003 Jun; 77(12):6637-44. PubMed ID: 12767983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in the new anti-HIV drugs acting on chemokine receptor].
    Dong XC; Wen R
    Yao Xue Xue Bao; 2001 Oct; 36(10):796-800. PubMed ID: 12579985
    [No Abstract]   [Full Text] [Related]  

  • 5. SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development.
    Kumar S; Choi WT; Dong CZ; Madani N; Tian S; Liu D; Wang Y; Pesavento J; Wang J; Fan X; Yuan J; Fritzsche WR; An J; Sodroski JG; Richman DD; Huang Z
    Chem Biol; 2006 Jan; 13(1):69-79. PubMed ID: 16426973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.
    Hartley O; Gaertner H; Wilken J; Thompson D; Fish R; Ramos A; Pastore C; Dufour B; Cerini F; Melotti A; Heveker N; Picard L; Alizon M; Mosier D; Kent S; Offord R
    Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16460-5. PubMed ID: 15545608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor-directed agents as novel anti-HIV-1 therapies.
    Mills SG; DeMartino JA
    Curr Top Med Chem; 2004; 4(10):1017-33. PubMed ID: 15193136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES.
    Nardese V; Longhi R; Polo S; Sironi F; Arcelloni C; Paroni R; DeSantis C; Sarmientos P; Rizzi M; Bolognesi M; Pavone V; Lusso P
    Nat Struct Biol; 2001 Jul; 8(7):611-5. PubMed ID: 11427892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure and structural mechanism of a novel anti-human immunodeficiency virus and D-amino acid-containing chemokine.
    Liu D; Madani N; Li Y; Cao R; Choi WT; Kawatkar SP; Lim MY; Kumar S; Dong CZ; Wang J; Russell JD; Lefebure CR; An J; Wilson S; Gao YG; Pallansch LA; Sodroski JG; Huang Z
    J Virol; 2007 Oct; 81(20):11489-98. PubMed ID: 17686848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display.
    Dorgham K; Cerini F; Gaertner H; Melotti A; Rossitto-Borlat I; Gorochov G; Hartley O
    Methods Enzymol; 2016; 570():47-72. PubMed ID: 26921941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines and chemokine receptors in HIV infection: role in pathogenesis and therapeutics.
    Suresh P; Wanchu A
    J Postgrad Med; 2006; 52(3):210-7. PubMed ID: 16855325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T lymphocyte-derived chemokines and other HIV-suppressive factors: mini-review.
    Furci L; Polo S; Lusso P
    J Chemother; 1998 Apr; 10(2):146-9. PubMed ID: 9603642
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation, and this is mediated through interaction of trichosanthin and chemokine receptors.
    Zhao J; Ben LH; Wu YL; Hu W; Ling K; Xin SM; Nie HL; Ma L; Pei G
    J Exp Med; 1999 Jul; 190(1):101-11. PubMed ID: 10429674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES.
    Rusconi S; Merrill DP; La Seta-Catamancio S; Citterio P; Offord RE; Hirsch MS
    AIDS; 1999 Jun; 13(9):1144-5. PubMed ID: 10397549
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemokines and their receptors in lymphocyte traffic and HIV infection.
    Loetscher P; Moser B; Baggiolini M
    Adv Immunol; 2000; 74():127-80. PubMed ID: 10605606
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds.
    Howard OM; Dong HF; Oppenheim JJ; Insaf S; Santhosh KC; Paul G; Cushman M
    Bioorg Med Chem Lett; 2001 Jan; 11(1):59-62. PubMed ID: 11140734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering and screening the N-terminus of chemokines for drug discovery.
    Chevigné A; Fievez V; Schmit JC; Deroo S
    Biochem Pharmacol; 2011 Nov; 82(10):1438-56. PubMed ID: 21824467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptors and their role in leukocyte activation.
    Wells TN; Proudfoot AE; Power CA
    Immunol Lett; 1999 Jan; 65(1-2):35-40. PubMed ID: 10065624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine inhibitors for HIV.
    Eccleston A
    Nat Biotechnol; 1997 Aug; 15(8):709, 710. PubMed ID: 9255775
    [No Abstract]   [Full Text] [Related]  

  • 20. Roles of chemokines and chemokine receptors in HIV-1 infection.
    Murakami T; Yamamoto N
    Int J Hematol; 2000 Dec; 72(4):412-7. PubMed ID: 11197206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.